It has previously been demonstrated in prostate cancer that miR-330 acts as a tumour suppressor by downregulating E2F1 protein expression and the cellular levels of p-Akt, thereby promoting apoptosis of cancer cells [27]. The gene discussed is E2F1; the disease is prostate carcinoma.